Yarrow Bioscience, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
668K
on 2026-06-30, from 286K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-50 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
None
No at-the-market programme on file in the last 30 months.
Warrants
The 10-Q filed 2026-08-13 is not read yet.
Cash
Four quarters of operating cash flow to 2026-06-30 are not all on file.
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-09-11 | Public offering | 5,769,231 | $26.00 | $150.0M | 424B5 ↗ |
| 2026-07-28 | Private placement | not read | not read | $100.0M | 8-K ↗ |
| 2025-12-17 | Private placement | not read | not read | $100.0M | 8-K ↗ |
Also on file: a 1-for-50 reverse split, 2026-07-24 8-K ↗